Magellan Lends Lead Testing Platforms to Flint

One of Magellan Diagnostics' testing platforms is playing a small role in addressing the contaminated water crisis in Flint, Mich.

The Massachusetts-based lab has been shipping its LeadCare II testing platform to county health officials in Flint in order to test the levels of lead contamination in the population.

Flint has made national headlines since its governor-appointed city manager switched water supplies. The change caused lead and other contaminants to leach into the water for months. Health officials believe a large majority of the city's children have been exposed to lead. The Magellan system, which received U.S. Food and Drug Administration approval last year, can obtain test results from a blood sample within three minutes.

"It is critical to identify and monitor kids who have been exposed to lead. Our system is the fastest and easiest way to do this—it's simple to run, and in three minutes the doctor has an answer. People with potential exposure in Flint should have access to testing," said Magellan Chief Executive Officer Amy Winslow. "We are proud to partner with Genesee County and other community groups who want to implement screening programs. Too many people think lead exposure is a thing of the past. As Flint has shown, it still lurks in our environment and can cause major, lasting health issues."

Magellan spokesperson Matt Burke said that more than two dozen testing platforms have been shipped to Flint officials in recent weeks. The company was unable to say how many tests have been performed so far.

Takeaway: Magellan Diagnostics is using a significant health crisis to spread the word on its latest testing platform.